Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cardiovascular Disease and Cancer: Evidence for Shared Disease Pathways and Pharmacologic Prevention Publisher Pubmed



Masoudkabir F1 ; Sarrafzadegan N2, 3 ; Gotay C3, 4 ; Ignaszewski A5 ; Krahn AD5 ; Davis MK5 ; Franco C5 ; Mani A6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardiac Primary Prevention Research Center, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
  4. 4. Cancer Control Research Program, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
  5. 5. Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
  6. 6. Yale Cardiovascular Genetics Program, Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States

Source: Atherosclerosis Published:2017


Abstract

Cardiovascular disease (CVD) and cancer are leading causes of mortality and morbidity worldwide. Strategies to improve their treatment and prevention are global priorities and major focus of World Health Organization's joint prevention programs. Emerging evidence suggests that modifiable risk factors including diet, sedentary lifestyle, obesity and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders. In this review, we will discuss the shared genetic and molecular factors central to CVD and cancer and how the strategies commonly used for the prevention of atherosclerotic vascular disease can be applied to cancer prevention. © 2017 Elsevier B.V.
Other Related Docs
11. Metformin: Prevention of Genomic Instability and Cancer: A Review, Mutation Research - Genetic Toxicology and Environmental Mutagenesis (2018)
13. Meta-Analysis of Gene Expression Profiles in Acute Promyelocytic Leukemia Reveals Involved Pathways, International Journal of Hematology-Oncology and Stem Cell Research (2017)
16. Metabolic Risk Factors of Ovarian Cancer: A Review, Jornal Brasileiro de Reproducao Assistida (2022)
18. Immunology of Cutaneous Tumors and Immunotherapy for Melanoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
19. Metformin and Long Non-Coding Rnas in Breast Cancer, Journal of Translational Medicine (2023)